Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

(2013)   LANCET

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study

(2012) Annette Wigertz et al.   BREAST CANCER RESEARCH AND TREATMENT

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

(2012) N. Lynn Henry et al.   JOURNAL OF CLINICAL ONCOLOGY

Cognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial

(2012) Eleanor Mann et al.   LANCET ONCOLOGY

Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time

(2011) C. Cluze et al.   ANNALS OF ONCOLOGY

Adherence to oral endocrine treatments in women with breast cancer: can it be improved?

(2011) Sheila A. Doggrell   BREAST CANCER RESEARCH AND TREATMENT

Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?

(2011) Uwe Güth et al.   BREAST CANCER RESEARCH AND TREATMENT

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

(2011) Jennifer C. Livaudais et al.   BREAST CANCER RESEARCH AND TREATMENT

Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer

(2011) Larissa Nekhlyudov et al.   BREAST CANCER RESEARCH AND TREATMENT

The Impact of Breast Care Nurses on Patients’ Satisfaction, Understanding of the Disease, and Adherence to Adjuvant Endocrine Therapy

(2011) Ute-Susann Albert et al.   Breast Care

Use of tamoxifen and aromatase inhibitors in a large population-based cohort of women with breast cancer

(2011) L Huiart et al.   BRITISH JOURNAL OF CANCER

Predicting Adherence to Tamoxifen for Breast Cancer Adjuvant Therapy and Prevention

(2011) J. H. Lin et al.   Cancer Prevention Research

Adherence to adjuvant therapy in post-menopausal breast cancer patients: a review

(2011) M. BANNING   EUROPEAN JOURNAL OF CANCER CARE

Association Between Prescription Co-Payment Amount and Compliance With Adjuvant Hormonal Therapy in Women With Early-Stage Breast Cancer

(2011) Alfred I. Neugut et al.   JOURNAL OF CLINICAL ONCOLOGY

Influence of Race, Insurance, Socioeconomic Status, and Hospital Type on Receipt of Guideline-Concordant Adjuvant Systemic Therapy for Locoregional Breast Cancers

(2011) Xiao-Cheng Wu et al.   JOURNAL OF CLINICAL ONCOLOGY

Differences Between Primary Care Physicians’ and Oncologists’ Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors

(2011) Arnold L. Potosky et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor-Positive Breast Cancer: A TEAM Study Analysis

(2011) W. van de Water et al.   ONCOLOGIST

Adherence to long-term adjuvant hormonal therapy for breast cancer

(2011) Carolyn Gotay et al.   Expert Review of Pharmacoeconomics & Outcomes Research

Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer

(2010) Rebecca L. Sedjo et al.   BREAST CANCER RESEARCH AND TREATMENT

Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy

(2010) Alastair M. Thompson et al.   BREAST CANCER RESEARCH AND TREATMENT

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

(2010) Dawn L. Hershman et al.   BREAST CANCER RESEARCH AND TREATMENT

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

(2010) Myrthe P. P. van Herk-Sukel et al.   BREAST CANCER RESEARCH AND TREATMENT

Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer

(2010) Vincent O. Dezentjé et al.   JOURNAL OF CLINICAL ONCOLOGY

Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients

(2010) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Clinical Practice Guideline Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer

(2010) Harold J. Burstein et al.   Journal of Oncology Practice

Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer

(2009) V. Ziller et al.   ANNALS OF ONCOLOGY

Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer

(2009) Lee S. Schwartzberg et al.   BREAST

Patient adherence and persistence with oral anticancer treatment

(2009) K. Ruddy et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy

(2009) Peyman Hadji   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Managing the toxicities of the aromatase inhibitors

(2009) Joanne E Mortimer   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer

(2009) Gretchen Kimmick et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients

(2009) J M Rae et al.   PHARMACOGENOMICS JOURNAL

Women's perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients' point of view

(2009) Isabelle Pellegrini et al.   PSYCHO-ONCOLOGY

Noncompliance with adjuvant radiation, chemotherapy, or hormonal therapy in breast cancer patients

(2008) Aye Moe Thu Ma et al.   AMERICAN JOURNAL OF SURGERY

Effectively nursing patients receiving aromatase inhibitor therapy

(2008) Y. Wengström   BREAST

Target and reality of adjuvant endocrine therapy in postmenopausal patients with invasive breast cancer

(2008) U Güth et al.   BRITISH JOURNAL OF CANCER

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

(2008) C McCowan et al.   BRITISH JOURNAL OF CANCER

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

(2008) Ann H. Partridge et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial

(2008)   LANCET ONCOLOGY

Evaluation of a group cognitive behavioural intervention for women suffering from menopausal symptoms following breast cancer treatment

(2008) Myra S. Hunter et al.   PSYCHO-ONCOLOGY

Predictors of Tamoxifen Discontinuation Among Older Women With Estrogen Receptor–Positive Breast Cancer

(2007) Cynthia Owusu et al.   JOURNAL OF CLINICAL ONCOLOGY